Pharmacotherapeutic Profile at a Center for Psychosocial Care Alcohol and Drugs (CAPS-ad) of Northeast Brazil
Article Sidebar
Main Article Content
Abstract
Objective: To verify the pharmacotherapeutic profile of users of a Psychosocial Care Center for Alcohol and Drugs in Drugs (CAPS-ad) in a capital city in northeastern Brazil. Methods: Exploratory, descriptive, retrospective study with a quantitative approach, performed on drug users over 18 years old, regardless of gender and ethnicity. Data (medications, clinical diagnosis, use of illicit drugs, among others) were collected from the institution's medical records. The analysis was conducted using descriptive statistics (absolute and relative frequencies, mean and standard deviation). Results: 60 medical records of patients being monitored at the CAPS-ad were analyzed, 83.3% of whom were male, with a predominance of patients aged between 30 and 39 years (35%), incomplete primary education (40%) and diagnosis ICD-10 F19 (mental and behavioral disorders due to the use of multiple drugs and the use of other psychoactive substances; 45%). The most prescribed drug class was benzodiazepines (23.8%), with the predominant use of the active component clonazepam (15.4%), followed by antidepressants (16.1%), with amitriptyline (4.9%) being the most prescribed when compared to others in the same class. Conclusion: The study highlighted the importance of the pharmacist's role with the health team to promote the rational use of medicines and the control of adverse reactions and success in drug therapy.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International 
, allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.
References
2. Ministério da Saúde (BR). Fundação Oswaldo Cruz. III Levantamento nacional sobre o uso de drogas pela população brasileira. Rio de Janeiro: ICICT/FIOCRUZ; 2017.
3. Ministério da Justiça e Cidadania (BR). Efeitos de substâncias psicoativas: módulo 2. 11. ed. Brasília: Secretaria Nacional de Políticas sobre Drogas; 2017[cited 2020 Jul 10]. 146 p. Avaiable from : www.supera.org.br/@/material/mtd/pdf/SUP/SUP_Mod2.pdf
4. Ministério da Saúde (BR). Portaria nº 3.088, de 23 de dezembro de 2011. Brasília, DF; 2011[cited 2020 Jul 08]. Avaiable from: bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt3088_23_12_2011_rep.html
5. Borba LO, Maftum MA, Vayego SA, Kalinke LP, Ferreira ACZ, Capistrano FC, et al. Perfil do portador de transtorno mental em tratamento no centro de atenção psicossocial (CAPS). Rev Min Enferm. 2017;21:e1010. doi: 10.5935/1415-2762.20170020
6. Araújo SHM. Perfil farmacoterapêutico de adolescentes usuários de um centro de atenção psicossocial álcool e drogas infanto juvenil do estado de Goiás [Dissertation]. Goiânia: Universidade Federal de Goiás; 2017 [cited 2019 Oct 19]. Avaiable from: repositorio.bc.ufg.br/tede/handle/tede/7570.
7. Franskoviak LD, da Silva TE, da Silva Carlotto M, Batista EC. Perfil epidemiológico de usuários de psicotrópicos de um CAPS da Zona da Mata do Estado de Rondônia. RIES. 2018 [cited 2020 Jul 27];7(1):68-82. Avaiable from: periodicos.uniarp.edu.br/index.php/ries/article/view/1128/760
8. Secoli SR. Polifarmácia: interações e reações adversas no uso de medicamentos por idosos. Rev Bras Enferm. 2010;63(1):136-140. doi: 10.1590/S0034-71672010000100023
9. Maciel SC, Silva FF, Pereira CA, Dias CCV, Alexandre TMO. Cuidadoras de dependentes químicos: um estudo sobre a sobrecarga familiar. Psicol Teor Pesq. 2018;34:e34416. doi: 10.1590/0102.3772e34416
10. Miotto MHMB, Alves NF, Calmon MV, Barcellos LA. Impacto dos problemas orais na qualidade de vida de dependentes químicos em recuperação num Centro de tratamento. Port J Public Health. 2017;35(1):30-6. doi: 10.1159/000477647
11. Paiva HND, Silva CJDP, Galo R, Zarzar PM, Paiva PCP. Associação do uso de drogas lícitas e ilícitas, sexo e condição socioeconômica entre adolescentes de 12 anos de idade. Cad Saúde Colet. 2018;26(2):153-59. doi: 10.1590/1414-462x201800020048
12. Fernandes MA, Pinto KLC, Teixeira Neto JA, Magalhães JM, Carvalho CMS, de Oliveira ALCB. Transtornos mentais e comportamentais por uso de substâncias psicoativas em hospital psiquiátrico. SMAD Rev Eletr Saúde Mental Álcool Drog. 2018;13(2):64-70. doi: 10.11606/issn.1806-6976.v13i2p64-70
13. Azevedo RCS, Oliveira KD, Lima e Silva LFA, Koller K, Marques ACPR, Ribeiro M. 13. Associação Brasileira de Psiquiatria. Abuso e Dependência de Múltiplas Drogas [Internet]. 2012 [cited 2020 Jul 27]. Avaiable from: diretrizes.amb.org.br/_BibliotecaAntiga/abuso_e_dependência_de_multiplas_drogas.pdf
14. Freitas J, Lima M, Santos J, Lopes D, Barbosa V, Pachú CO. Consumo de álcool: influência familiar entre escolares. Biofarm [Internet]. 2015[cited 2019 Oct 23];10(3):35-7. Avaiable from: revista.uepb.edu.br/index.php/biofarm/article/view/2605
15. Diehl A, Cordeiro D, Laranjeira R (eds). Dependência química: prevenção, tratamento e políticas públicas. Porto Alegre: Artmed Editora; 2018.
16. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA. 2009;281:1318-25. doi: 10.1001/jama.281.14.1318
17. Sachdeva A, Choudhary M, Chandra M. Alcohol Withdrawal Syndrome: Benzodiazepines and Beyond. J Clin Diagn Res. 2015;9(9):VE01-VE07. doi: 10.7860/JCDR/2015/13407.6538
18. Jesus RS, Sangoi, RS, Taschetto PL, de Brum TF, Piana M, Limberger JB. Perfil farmacoterapêutico de usuários de crack internados em hospital público de Santa Maria-RS. RDS [Internet]. 2016 [cited 2019 Sep 19];15(1):37-46. Avaiable from: periodicos.ufn.edu.br/index.php/disciplinarumS/article/view/1063
19. Blevins D, Wang X, Sharma S, Ait‐Daoud N. Impulsiveness as a predictor of topiramate response for cocaine use disorder. Am J Addict. 2019;28(2):71-6. doi:10.1111/ajad.12858
20. Agência Nacional de Vigilância Sanitária. Transtornos de ansiedade [Internet]. 2013 [cited 2020 Jul 27]. Avaiable from: http://portal.anvisa.gov.br/documents/33884/412285/Boletim+Sa%C3%BAde+e+Economia+n%C2%BA+10/a45e002d-df42-4345-a3a2-67bf2451870c
21. Garbutt JC. Efficacy and tolerability of naltrexone in the management of alcohol dependence. Curr Pharm Design. 2019;16(19):2091-7. doi: 10.2174/138161210791516459
22. Rösner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M. Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev. 2010;12:CD001867. doi: 10.1002/14651858.CD001867.pub3
23. Collins GB, McAllister MS, Adury K. Drug adjuncts for treating alcohol dependence. Cleve Clin J Med. 2006;73(7):641-52. doi: 10.3949/ccjm.73.7.641
24. Associação Brasileira de Psiquiatria. Abuso e dependência: crack. Rev Assoc Med Bras. 2012;58(2):141-53. doi: 10.1590/S0104-42302012000200008
25. Andrade JM, de Souza FAF, Duarte JF, Leite PIP, de Medeiros P MC. Avaliação da adesão ao tratamento com antidepressivos em pacientes de uma farmácia pública no interior do Ceará. Rev Mult Psicol. 2018;12(42):203-12. doi: 10.14295/idonline.v12i42.1306
26. Silva JC, Dullius CL, Castoldi DR. A relação entre o uso de psicofármacos e o processo de psicoterapia na infância. Rev Psicol [Internet]. 2011 [cited 2019 Sep 28];2(1):86-94. Avaiable from: www.periodicos.ufc.br/psicologiaufc/article/view/77